Skip to main navigation Skip to search Skip to main content

STTR Phase I: High-resolution, spatially selective intraspinal stimulator to restore sensation in spinal cord injury patients.

Project: Research

Abstract & Details

Description

Award ID: 2403910

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel custom-made micro-probe electrode system for restoring organ function in nervous paralysis and paralysis-related conditions such as neurogenic bladder or fecal incontinence. The electrode system aims to provide real-time, bi-directional, closed-loop spinal cord machine interface to restore both sensation and volitional motor control in spinal cord injury (SCI) patients. The system aims to provide restorative function for the 5.4M US paralysis victims, while providing smaller, more accurate, higher capacity implantable electrode platform for the $7.6 B neurorehabilitation and neurostimulation market. This Small Business Technology Transfer (STTR) Phase I project aims to demonstrate the preclinical feasibility of a novel spinal cord neural interface as an effective scalable platform for rehabilitating paralysis-related conditions including neurogenic bladder and mobility. This project will develop a new type of neural interface that delivers selective stimulation to specific targeted regions of the patients spinal cord in order to evoke a target sensation. For example, bladder fullness will trigger the proposed intraspinal stimulator to deliver safe current pulses to the patients spinal cord to reenable the sensation of bladder fullness. The proposed probe will also sense the patients intention to urinate and relay the signal to a bladder stimulator to reenable patients control over their micturition. Nanopatterned stimulating electrodes will be fabricated and coupled with custom-designed complementary metal oxide semiconductor (CMOS) chips to deliver safe and spatially selective current pulses. The system aims to bypass the spinal cord injury to restore communication between the subjects body and brain. The system will be validated in rodent nervous models and characterized for future human use. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Edward Chinchoy
StatusClosed
Effective start/end date06/15/2405/31/25

Lead and Sub-Awardee Organization(s)

Funding

  • STTR Phase I: $274,976.00

Active Fiscal Year

  • FY2024
  • FY2025

Start Fiscal Year

  • FY2024

TIP Programs

  • STTR Phase I

Small Business

  • Yes

Key Technology Areas

  • Biotechnology
  • (confidence score: 98%)

Technology Foci

  • Medical Technology
  • (confidence score: 96%)

Congressional District at Award

  • District n. 30 of California

Current Congressional District

  • District n. 30 of California

United States

  • California

Core Based Statistical Area (CBSA)

  • Los Angeles-Long Beach-Anaheim, CA

County

  • County: Los Angeles, CA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine